GERD
gerd · society: ACG
← back to Gastroenterology & Hepatology
Summary
The ACG 2022 GERD guideline updates the 2013 version with evidence-based recommendations spanning diagnosis, pharmacologic and lifestyle therapy, refractory disease, extraesophageal symptoms, and surgical/endoscopic interventions. PPIs remain first-line medical therapy, but the document emphasizes stricter criteria for diagnosing GERD before chronic acid suppression, more rigorous workup of “refractory” symptoms (since most are not truly reflux-related), and provides reassurance regarding the safety of long-term PPI use based on the COMPASS trial. New attention is given to magnetic sphincter augmentation (MSA), transoral incisionless fundoplication (TIF), and the limited role of surgery for extraesophageal symptoms.
Current guideline: ACG 2022 GERD Guideline · 
download Anki sub-deck
Versions
- 2022 · ACG — ACG 2022 GERD Guideline